Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Implications of the prion-related Q/N domains in TDP-43 and FUS.

Udan M, Baloh RH.

Prion. 2011 Jan-Mar;5(1):1-5. Epub 2011 Jan 1. Review.

2.

Protein aggregates and regional disease spread in ALS is reminiscent of prion-like pathogenesis.

Verma A.

Neurol India. 2013 Mar-Apr;61(2):107-10. doi: 10.4103/0028-3886.111109. Review.

3.

How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?

Baloh RH.

Curr Opin Neurol. 2012 Dec;25(6):701-7. doi: 10.1097/WCO.0b013e32835a269b. Review.

PMID:
23041957
4.

RNA-binding proteins with prion-like domains in ALS and FTLD-U.

Gitler AD, Shorter J.

Prion. 2011 Jul-Sep;5(3):179-87. doi: 10.4161/pri.5.3.17230. Epub 2011 Jul 1. Review.

5.

Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).

Bentmann E, Neumann M, Tahirovic S, Rodde R, Dormann D, Haass C.

J Biol Chem. 2012 Jun 29;287(27):23079-94. doi: 10.1074/jbc.M111.328757. Epub 2012 May 4.

6.

The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.

King OD, Gitler AD, Shorter J.

Brain Res. 2012 Jun 26;1462:61-80. doi: 10.1016/j.brainres.2012.01.016. Epub 2012 Jan 21. Review.

7.

Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.

Ito D, Suzuki N.

Neurology. 2011 Oct 25;77(17):1636-43. doi: 10.1212/WNL.0b013e3182343365. Epub 2011 Sep 28. Review.

8.

Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.

Sun Z, Diaz Z, Fang X, Hart MP, Chesi A, Shorter J, Gitler AD.

PLoS Biol. 2011 Apr;9(4):e1000614. doi: 10.1371/journal.pbio.1000614. Epub 2011 Apr 26.

9.

Molecular basis of amyotrophic lateral sclerosis.

Liscic RM, Breljak D.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):370-2. doi: 10.1016/j.pnpbp.2010.07.017. Epub 2010 Jul 23. Review.

PMID:
20655970
10.

Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.

Neumann M.

Rev Neurol (Paris). 2013 Oct;169(10):793-8. doi: 10.1016/j.neurol.2013.07.019. Epub 2013 Sep 5. Review.

PMID:
24011641
11.

Modeling ALS and FTLD proteinopathies in yeast: an efficient approach for studying protein aggregation and toxicity.

Kryndushkin D, Shewmaker F.

Prion. 2011 Oct-Dec;5(4):250-7. doi: 10.4161/pri.17229. Epub 2011 Oct 1. Review.

12.

Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).

Lourenco GF, Janitz M, Huang Y, Halliday GM.

Neurobiol Dis. 2015 Oct;82:445-54. doi: 10.1016/j.nbd.2015.07.011. Epub 2015 Jul 26. Review.

PMID:
26220395
13.

TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.

Mackenzie IR, Rademakers R, Neumann M.

Lancet Neurol. 2010 Oct;9(10):995-1007. doi: 10.1016/S1474-4422(10)70195-2. Review.

PMID:
20864052
14.

Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.

Finelli MJ, Liu KX, Wu Y, Oliver PL, Davies KE.

Hum Mol Genet. 2015 Jun 15;24(12):3529-44. doi: 10.1093/hmg/ddv104. Epub 2015 Mar 19.

15.

Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.

Neumann M, Valori CF, Ansorge O, Kretzschmar HA, Munoz DG, Kusaka H, Yokota O, Ishihara K, Ang LC, Bilbao JM, Mackenzie IR.

Acta Neuropathol. 2012 Nov;124(5):705-16. doi: 10.1007/s00401-012-1020-6. Epub 2012 Jul 28.

PMID:
22842875
16.

Genetic contribution of FUS to frontotemporal lobar degeneration.

Van Langenhove T, van der Zee J, Sleegers K, Engelborghs S, Vandenberghe R, Gijselinck I, Van den Broeck M, Mattheijssens M, Peeters K, De Deyn PP, Cruts M, Van Broeckhoven C.

Neurology. 2010 Feb 2;74(5):366-71. doi: 10.1212/WNL.0b013e3181ccc732.

PMID:
20124201
17.

FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis.

Broustal O, Camuzat A, Guillot-Noël L, Guy N, Millecamps S, Deffond D, Lacomblez L, Golfier V, Hannequin D, Salachas F, Camu W, Didic M, Dubois B, Meininger V, Le Ber I, Brice A; French clinical and genetic research network on FTD/FTD-MND.

J Alzheimers Dis. 2010;22(3):765-9.

PMID:
21158017
18.

From nucleation to widespread propagation: A prion-like concept for ALS.

Maniecka Z, Polymenidou M.

Virus Res. 2015 Sep 2;207:94-105. doi: 10.1016/j.virusres.2014.12.032. Epub 2015 Feb 2. Review.

19.

Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.

Bentmann E, Haass C, Dormann D.

FEBS J. 2013 Sep;280(18):4348-70. doi: 10.1111/febs.12287. Epub 2013 May 9. Review.

20.

TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?

Strong MJ, Volkening K.

FEBS J. 2011 Oct;278(19):3569-77. doi: 10.1111/j.1742-4658.2011.08277.x. Epub 2011 Sep 6. Review.

Supplemental Content

Support Center